[ad_1]

Longeveron Inc. (NASDAQ:LGVN) Q2 2023 Earnings Convention Name August 11, 2023 8:00 AM ET

Firm Members

Mike Moyer – Managing Director, LifeSci Advisors, LLC

Wa’el Hashad – Chief Government Officer

Nataliya Agafonova – Chief Medical Officer

Lisa Locklear – Chief Monetary Officer

Joshua Hare – Co-Founder, Chief Science Officer and Chairman

Convention Name Members

Michael Okunewitch – Maxim Group

Operator

Greetings, and welcome to the Longeveron’s Second Quarter 2023 Earnings name. At the moment, all contributors are in a listen-only mode. A short question-and-answer session will observe the formal presentation. [Operator Instructions] As a reminder, this convention is recorded.

It’s now my pleasure to introduce host, Mike Moyer, Investor Relations. Thanks, sir. It’s possible you’ll start.

Mike Moyer

Thanks, operator. Good morning, everybody, and welcome to Longeveron’s Second Quarter 2023 Outcomes Convention Name. We are going to present a enterprise replace and talk about monetary outcomes for the quarter ended June 30, 2023. Earlier this morning, we issued a press launch with these outcomes, which could be discovered underneath the Investor part of our web site.

Becoming a member of the decision in the present day by the next members of Longeveron’s administration staff. Mr. Wa’el Hashad, Chief Government Officer; Natalia Agafonova, Chief Medical Officer; and Lisa Locklear, Chief Monetary Officer. Mr. Hashad will start with a short company overview. Then Dr. Natalia Agapitova will evaluation on Longeveron’s current progress in its medical applications and Ms. Locklear will evaluation monetary outcomes for the 2023 second quarter. Following the corporate’s ready remarks, we are going to open the decision to questions from overlaying analysts.

As a reminder, throughout this name, we will likely be making forward-looking statements, that are topic to varied dangers and uncertainties that would trigger our precise outcomes to vary materially from these statements. Any such statements needs to be thought-about along side cautionary statements in our press releases and threat elements mentioned

[ad_2]

Source link

Author